Rajeev M. Shah, Director at Cytek Biosciences, Inc. (CTKB), bought 1,294,528 shares at $12.86 ($16.5M) on 2022-03-08, disclosed to the SEC on 2022-03-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.99 | 63,662 | $827K | 5.0% |
| 2 | $12.99 | 63,662 | $827K | 5.0% |
| 3 | $12.61 | 337,901 | $4.3M | 25.8% |
| 4 | $12.61 | 337,901 | $4.3M | 25.8% |
| 5 | $12.86 | 245,701 | $3.2M | 19.2% |
| 6 | $12.86 | 245,701 |
| $3.2M |
| 19.2% |
| Total | $12.74 avg | 1,294,528 | $16.5M | 100% |
| Filing → |
| SEPN | BUY | 2024-10-30 | $75.1M | — | Filing → |
| AVTE | BUY | 2024-06-20 | $3.1M | — | Filing → |
| HOWL | BUY | 2023-01-10 | $4.1M | — | Filing → |